Patent-settlement expenditure treated as commercially expedient revenue outlay, with foreign-law restrictions inapplicable before the prospective amen...
International transaction benchmarking restricts transfer pricing adjustments to associated-enterprise dealings, while functional comparability govern...
Page of 4786
Press 'Enter' after typing page number.
161 to 180 of 95715 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
Approval is granted for Scientific Research under section 45(3)(b) of the Income-tax Act, 2025 read with Rule 35 of the Income-tax Rules, 2026. The approval applies to the specified company for five tax years, from Tax Year 2026-27 through Tax Year 2030-31, enabling it to be treated as approved for the stated scientific research purpose during that period. The notification certifies that retrospective effect does not adversely affect any person.
Approval is granted for Scientific Research under section 45(3)(b) of the Income-tax Act, 2025 read with Rule 35 of the Income-tax Rules, 2026. The approval applies to the specified company for five tax years, from Tax Year 2026-27 through Tax Year 2030-31, enabling it to be treated as approved for the stated scientific research purpose during that period. The notification certifies that retrospective effect does not adversely affect any person.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 4786
Join Channel
TaxTMI 
